このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Kilitch Drugs (India) マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Mukund Mehta
最高経営責任者
₹6.0m
報酬総額
| CEO給与比率 | 100.0% |
| CEO在任期間 | 32.2yrs |
| CEOの所有権 | 7.1% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 8.3yrs |
経営陣の近況
Recent updates
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05
Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump
Feb 02We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease
Jan 30Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings
Nov 17Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why
Sep 23These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors
May 05Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today
Apr 08These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 13Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03
Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?
Aug 20Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 16CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹146m |
| Dec 31 2023 | n/a | n/a | ₹146m |
| Sep 30 2023 | n/a | n/a | ₹140m |
| Jun 30 2023 | n/a | n/a | ₹117m |
| Mar 31 2023 | ₹6m | ₹6m | ₹104m |
| Dec 31 2022 | n/a | n/a | ₹98m |
| Sep 30 2022 | n/a | n/a | ₹85m |
| Jun 30 2022 | n/a | n/a | ₹83m |
| Mar 31 2022 | ₹6m | ₹6m | ₹74m |
| Dec 31 2021 | n/a | n/a | ₹52m |
| Sep 30 2021 | n/a | n/a | ₹63m |
| Jun 30 2021 | n/a | n/a | ₹62m |
| Mar 31 2021 | ₹6m | n/a | ₹37m |
| Dec 31 2020 | n/a | n/a | ₹17m |
| Sep 30 2020 | n/a | n/a | ₹4m |
| Jun 30 2020 | n/a | n/a | -₹3m |
| Mar 31 2020 | ₹6m | n/a | ₹8m |
報酬と市場: Mukundの 総報酬 ($USD 71.92K ) は、 Indian市場 ($USD 38.34K ) の同規模の企業の平均を上回っています。
報酬と収益: Mukundの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Mukund Mehta (71 yo)
32.2yrs
在職期間
₹6,000,000
報酬
Mr. Mukund Prataprai Mehta, B.Com, LL B., serves as the Chairman and Managing Director at Kilitch Drugs (India) Limited and has been its Executive Director since May 12, 1992. Mr. Mehta served as the Compl...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman & MD | 32.2yrs | ₹6.00m | 7.09% ₹ 383.0m | |
| Whole-time Director | 6.8yrs | ₹8.40m | 20.92% ₹ 1.1b | |
| Whole Time Director | 9.7yrs | ₹2.40m | データなし | |
| Independent & Non Executive Director | 16.1yrs | ₹25.00k | データなし | |
| Non-Executive Independent Director | 6.3yrs | ₹30.00k | データなし | |
| Independent Non-Executive Director | 6.1yrs | ₹5.00k | データなし |
8.3yrs
平均在職期間
65yo
平均年齢
経験豊富なボード: KILITCHの 取締役会 は 経験豊富 であると考えられます ( 8.2年の平均在任期間)。